488 related articles for article (PubMed ID: 29073620)
21. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between PI3 kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor.
Niba ET; Nagaya H; Kanno T; Tsuchiya A; Gotoh A; Tabata C; Kuribayashi K; Nakano T; Nishizaki T
Cell Physiol Biochem; 2013; 31(6):905-13. PubMed ID: 23817184
[TBL] [Abstract][Full Text] [Related]
23. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
[TBL] [Abstract][Full Text] [Related]
24. ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells.
Tian ZJ; An W
Cell Res; 2004 Apr; 14(2):141-7. PubMed ID: 15115615
[TBL] [Abstract][Full Text] [Related]
25. bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.
Trisciuoglio D; Iervolino A; Candiloro A; Fibbi G; Fanciulli M; Zangemeister-Wittke U; Zupi G; Del Bufalo D
J Biol Chem; 2004 Feb; 279(8):6737-45. PubMed ID: 14660675
[TBL] [Abstract][Full Text] [Related]
26. Atractylenolide I inhibits lipopolysaccharide-induced inflammatory responses via mitogen-activated protein kinase pathways in RAW264.7 cells.
Ji G; Chen R; Zheng J
Immunopharmacol Immunotoxicol; 2014 Dec; 36(6):420-5. PubMed ID: 25270720
[TBL] [Abstract][Full Text] [Related]
27. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
[TBL] [Abstract][Full Text] [Related]
28. Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.
Hann SS; Tang Q; Zheng F; Zhao S; Chen J; Wang Z
Mol Cancer; 2014 Jun; 13():149. PubMed ID: 24925061
[TBL] [Abstract][Full Text] [Related]
29. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
Udayakumar TS; Stratton MS; Nagle RB; Bowden GT
Neoplasia; 2002; 4(1):60-7. PubMed ID: 11922392
[TBL] [Abstract][Full Text] [Related]
31. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
[TBL] [Abstract][Full Text] [Related]
32. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
33. Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65.
Hann SS; Zheng F; Zhao S
J Exp Clin Cancer Res; 2013 Jul; 32(1):43. PubMed ID: 23867003
[TBL] [Abstract][Full Text] [Related]
34. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
[TBL] [Abstract][Full Text] [Related]
35. PKCδ-dependent activation of ERK1/2 leads to upregulation of the human NHE2 transcriptional activity in intestinal epithelial cell line C2BBe1.
Muthusamy S; Shukla S; Amin MR; Cheng M; Orenuga T; Dudeja PK; Malakooti J
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G317-25. PubMed ID: 22052014
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
[TBL] [Abstract][Full Text] [Related]
37. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
[TBL] [Abstract][Full Text] [Related]
38. Intranuclear crosstalk between extracellular regulated kinase1/2 and signal transducer and activator of transcription 3 regulates JEG-3 choriocarcinoma cell invasion and proliferation.
Morales-Prieto DM; Ospina-Prieto S; Chaiwangyen W; Weber M; Hölters S; Schleussner E; Fitzgerald JS; Markert UR
ScientificWorldJournal; 2013; 2013():259845. PubMed ID: 24288470
[TBL] [Abstract][Full Text] [Related]
39. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
Han S; Sidell N; Roman J
Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666
[TBL] [Abstract][Full Text] [Related]
40. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway.
Ni Y; Wu S; Wang X; Zhu G; Chen X; Ding Y; Jiang W
J Cell Biochem; 2018 Jul; 119(7):6104-6112. PubMed ID: 29575175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
